Research Roundup

Factors that increase risk for deep or nonpalpable implant, 12-hour vs. 24-hour mifepristone-misoprostol interval, and two studies reinforcing the safety and efficacy of no-test medication abortion.

Patient characteristics of IUD placement under sedation, two studies on EC efficacy, substance use and anxiety among patients seeking an abortion, and genital herpes prevalence.

A patient-centered decision aid for tubal sterilization counseling, IUD self-removal experiences, and counseling about pain and medication abortion.

OTC birth control pill self-selection, adherence, and interest; IUD expulsion risks; and IUD and implant side effects.

Abortion information on TikTok, doxy-PEP effectiveness in cis-gendered women; new data on UPA-EC and implant insertion; and a survey of pain with IUD insertion.

Young people’s concerns about birth control and fertility, expanding EPT and PrEP in the ED, spike in EC demand around the New Year, and abortion decision making.

Highlighting one notable research article from each Research Roundup in 2023.

Pain management during procedural abortion, serum etonogestrel levels not associated with mood changes during implant use, and clinical considerations when patients are traveling for abortion care.